Meeting Banner
Abstract #1987

Clinical Translation of VSI Using Ferumoxytol: Feasibility in a Phase I Oncology Clinical Trial Population

Jill Fredrickson1, Natalie Serkova2, Richard Carano1, Shelby Wyatt1, Andrea Pirzkall1, Colin Weekes2, Jeffrey Silverman3, Lee Rosen4, Alex de Crespigny1

1Genentech, South San Francisco, CA, United States; 2University of Colorado Hospital, Denver, CO; 3Landmark Imaging, LLC, Santa Monica, CA; 4Premiere Oncology, Santa Monica, CA

Vessel size imaging (VSI) metrics acquired using ferumoyxtol and stock pulse sequences in a Phase 1 patient population with advanced solid tumors are compared to pre-clinical results. Despite using half the ferumoxytol dose, % changes in both R2 and R2* are much greater in human liver metastases than in xenografts. Average vessel density is lower in humans due to the greater increase in ∆R2*. Clinical VSI is feasible using stock pulse sequences in a Phase 1 population; in particular, the high level of ferumoxytol in the normal liver does not prevent the measurement of VSI metrics in liver metastases.

Abstract PDF

Keywords

acquiring addition advanced affected agent agents allows analyzed approved arrow attributed blood boards clinical clinically conducted contrast course created delayed density derived despite diffusion done dose evaluated evaluating evolution expected fact feasibility flow focused function generated gradient greater half heterogeneity histograms hospital hours human implemented indicates injection institutional iron kidney landmark lesion lesions likely liver lives local maps measures median metastases metrics mice mouse much necrotic oncology oxide paramagnetic part partially particular partly patient patients perfusion permeability population post premiere prevent primarily prior protocol protocols pulse recovery refinement representative review scanners scanning screening seem segmented similarly slice solid south species spin stock stroke successfully system table targeted tissue translation transverse trial tumor tumors turbo uptake valuable variability vascular vessel viable volume